Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Intended for Healthcare Professionals
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
  • Subscribe BJGP on YouTube
Intended for Healthcare Professionals
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
Clinical Intelligence

The atypical presentation of COVID-19 as gastrointestinal disease: key points for primary care

John Ong, Yock Young Dan and Jenny G Low
British Journal of General Practice 2020; 70 (696): 360-361. DOI: https://doi.org/10.3399/bjgp20X710705
John Ong
Department of Engineering, Materials Engineering & Materials — Tissue Interactions Group, University of Cambridge, Cambridge, UK; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; East of England Deanery, Gastroenterology Specialty Training Programme, Cambridge, UK.
Roles: Doctoral fellow and gastroenterology registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yock Young Dan
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Roles: Head and associate professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenny G Low
Department of Infectious Diseases, Singapore General Hospital, Singapore; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
Roles: Associate professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info
  • eLetters
  • PDF
Loading

INTRODUCTION

Since the SARS-CoV2 outbreak in Wuhan, China, in late 2019, the world has been ravaged by a roaring pandemic. Unlike coronavirus SARS-CoV that caused the severe acute respiratory syndrome (SARS) outbreak in 2002, SARS-CoV2 has proven to be more contagious and difficult to control. A key challenge is that the disease presentation can be very variable: patients in the early phase of infection may be asymptomatic, have subclinical symptoms, or atypical symptoms of COVID-19. This, compounded with the lack of easily accessible diagnostic tests, makes it challenging to diagnose COVID-19 in the community.

The most common symptoms of patients with COVID-19 are fever (72–88%) and cough (68–83%).1,2 A sore throat may be present in 14–61% of patients, and dyspnoea is usually seen in severe cases and is less frequent (11–19%).1,2 Other non-specific symptoms such as myalgia, headaches, rhinorrhoea, anosmia, ageusia, nasal congestion, conjunctivitis, and haemoptysis have been reported but are comparatively infrequent. However, of significant concern is the atypical presentation of gastrointestinal (GI) symptoms.

Early experience in Wuhan illustrated how a cluster outbreak occurred from a single index patient being mistakenly admitted to surgical services for abdominal pain. This resulted in nosocomial spread to 10 healthcare workers and four other patients, all presenting with abdominal symptoms of diarrhoea, nausea, and loss of appetite.3

COVID-19 AND LOWER GASTROINTESTINAL SYMPTOMS

Non-bloody diarrhoea as a main presenting complaint has been observed in approximately 20% of all patients with COVID-19.4,5 In a study of 204 hospitalised patients with COVID-19 in China, 18.6% (38/204) had respiratory symptoms with a combination of abdominal pain, diarrhoea, and vomiting.5 Importantly, these GI symptoms including loss of appetite were commonly observed to precede the onset of respiratory symptoms and often delayed presentation to hospitals.

It was observed that 2.9% (6/204) of patients had GI symptoms without any respiratory symptoms but most had a fever. COVID-19 may also cause bloody diarrhoea but such cases are rare. Therefore, COVID-19 may be mistaken as gastroenteritis with or without febrile illness, inflammatory bowel disease (IBD), treatment-related diarrhoea, irritable bowel syndrome, or malignancy, especially in the early phase of the infection.

The exact mechanism of how diarrhoea is caused in COVID-19 is unknown but it is likely multifactorial. SARS-CoV2 binds to the angiotensin-converting enzyme 2 receptor (ACE2) to invade target cells, but ACE2 is also an important regulator of intestinal inflammation. Therefore, some hypothesise that this is the mechanism of intestinal injury by which diarrhoea is caused; however, approximately 70–80% of all patients with COVID-19 have normal stool consistency.2,5 Oro-faecal transmission of SARS-CoV2 remains debatable. Unfortunately, testing for the virus in stool samples of patients with diarrhoea is not a useful diagnostic solution. Only half of all patients with COVID-19 have viral ribonucleic acid (RNA) in their stool detectable by real-time polymerase chain reaction (RT-PCR), and, based on current understanding of the disease, faecal viral RNA positivity does not correlate with GI symptoms.4

A respiratory swab taken from the nasopharynx or throat is the most sensitive and accessible method of diagnosis at present, although rapid antigen detection kits are being developed. Routine diagnostic endoscopy for diarrhoea would be delayed at present because of the risk of aerosolisation and nosocomial transmission to uninfected patients or hospital staff. However, in the case of bloody diarrhoea when malignancy or acute colitis is suspected, current guidance by the British Society of Gastroenterology (BSG) allows for referrals to be discussed on a case-by-case basis.

Nonetheless, in the event where an atypical presentation of COVID-19 is suspected, national guidance on testing and isolation practices should be followed.

COVID-19 AND THE LIVER

Data from China and Singapore suggest that abnormal liver function tests (LFTs) can be present in 43–51% of all patients with COVID-19. The most common pattern of derangement is a hepatic transaminitis.4 Cholestatic LFTs are rare even though ACE2 is highly expressed in bile ducts. It is not known if LFT derangement secondary to SARS-CoV2 infection can exist in isolation without any COVID-19 symptoms or whether it exists as part of a yet undefined or complex syndrome.

Current studies are limited because they are cross-sectional and cannot control for pre-existing liver disease. Other confounding factors include the presence of myositis, concomitant use of antimicrobials, ischaemic hepatitis, and sepsis-related liver dysfunction. There is a paucity of data from liver biopsies; however, to date, acute liver failure from COVID-19 has not been reported. In mild COVID-19 infection, LFTs tend to resolve with time and the stoppage of antiviral therapy.4

However, in endemic areas, when faced with an acute presentation of non-specific or prodromal symptoms coupled with deranged LFTs, a mild rise in alanine aminotransferase or aspartate transaminase (<2 × ULN) with lymphopenia and leucopenia can be telling of COVID-19. However, other causes of acute LFT derangement such as viral hepatitis, autoimmune hepatitis, drug-induced liver injury, and metabolic liver disease should also be excluded. In any situation of uncertainty, hepatology advice should be sought.

Although the BSG and British Association for the Study of the Liver (BASL) have recommended social isolation measures for high-risk liver patients and the reduction of outpatient clinic activity, hospitals are exploring alternative means of maintaining patient care and providing advice such as virtual or telephone clinics. BSG and BASL guidance are also constantly updated, so it is important that all physicians looking after at-risk or complex GI patients review these guidelines regularly.

COVID-19 AND UPPER GASTROINTESTINAL SYMPTOMS

SARS-CoV2 has been found in gastric and duodenal biopsies, although no known associated pathology is known. Loss of appetite has been reported in as many as 39.7% of all patients with COVID-19; nausea, vomiting, and abdominal pain are less frequent (1.0–4.0%).3,5 However, these symptoms are not specific to the upper GI tract and the cause may be multifactorial.

CONCLUSION

In summary, an awareness that COVID-19 can mimic GI disease will help in its early detection and the prevention of spread while better screening tools are being developed. More needs to be understood as to why GI manifestations occur in only some patients.

The emergence of SARS-CoV2 has significantly affected clinical practices within the field of gastroenterology, and physicians should regularly keep abreast with updates to current guidelines during this uncertain and dynamic phase of the outbreak.

Acknowledgments

John Ong was supported by the WD Armstrong Doctoral Fellowship from the University of Cambridge and a development grant from the National University of Singapore. The views expressed are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research (NIHR), or the Department of Health.

Notes

Funding

None.

Provenance

Freely submitted; externally peer reviewed.

Competing interests

The authors have declared no competing interests.

Discuss this article

Contribute and read comments about this article: bjgp.org/letters

Footnotes

  • ©British Journal of General Practice 2020; 69: 360–361.

  • Received March 24, 2020.
  • Revision requested March 26, 2019.
  • Accepted March 28, 2020.
  • © British Journal of General Practice 2020

REFERENCES

  1. 1.↵
    1. World Health Organization
    Report of the WHO–China Joint Mission on coronavirus disease 2019 (COVID-19)2020https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf (accessed 8 Jun 2020).
  2. 2.↵
    1. Young BE,
    2. Ong SWX,
    3. Kalimuddin S,
    4. et al.
    Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in SingaporeJAMA20203231514881494doi:10.1001/jama.2020.3204
    OpenUrlCrossRef
  3. 3.↵
    1. Wang D,
    2. Hu B,
    3. Hu C,
    4. et al.
    Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, ChinaJAMA20203231110611069doi:10.1001/jama.2020.1585
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Ong J,
    2. Young BE,
    3. Ong S
    COVID-19 in gastroenterology: a clinical perspectiveGut202069611441145doi:10.1136/gutjnl-2020-321051
    OpenUrlFREE Full Text
  5. 5.↵
    1. Pan L,
    2. Mu M,
    3. Yang P,
    4. et al.
    Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional multicenter studyAm J Gastroenterol20201155766773doi:10.14309/ajg.0000000000000620
    OpenUrlCrossRefPubMed
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 70 (696)
British Journal of General Practice
Vol. 70, Issue 696
July 2020
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The atypical presentation of COVID-19 as gastrointestinal disease: key points for primary care
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The atypical presentation of COVID-19 as gastrointestinal disease: key points for primary care
John Ong, Yock Young Dan, Jenny G Low
British Journal of General Practice 2020; 70 (696): 360-361. DOI: 10.3399/bjgp20X710705

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The atypical presentation of COVID-19 as gastrointestinal disease: key points for primary care
John Ong, Yock Young Dan, Jenny G Low
British Journal of General Practice 2020; 70 (696): 360-361. DOI: 10.3399/bjgp20X710705
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • INTRODUCTION
    • COVID-19 AND LOWER GASTROINTESTINAL SYMPTOMS
    • COVID-19 AND THE LIVER
    • COVID-19 AND UPPER GASTROINTESTINAL SYMPTOMS
    • CONCLUSION
    • Acknowledgments
    • Notes
    • Footnotes
    • REFERENCES
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • How to manage low testosterone level in men: a guide for primary care
  • Hyperparathyroidism (primary) NICE guideline: diagnosis, assessment, and initial management
Show more Clinical Intelligence

Related Articles

Cited By...

Intended for Healthcare Professionals

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2022 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242